Literature DB >> 3939971

In vivo reexpression of H-2 antigens in B16 melanoma cells.

P L Lollini1, M P Colombo, C De Giovanni, G Nicoletti, G Parmiani, G Prodi, P Nanni.   

Abstract

We have previously shown that B16-A (H-2b) murine melanoma cells, when cultured in vitro for more than ten passages, have an undetectable or reduced expression of H-2Kb and Db antigens, respectively. We have now studied the possibility to restore H-2 expression (measured by quantitative antisera absorption) in B16-A cells either by a limited (30 days) period of in vivo growth or by treatment with immune interferon. In vivo transplants in allogeneic H-2k or H-2d mice and in H-2-compatible but Mls and multiple non-H-2 loci incompatible mice restored the normal expression of Kb and Db antigens. Cells obtained from tumors grown in syngeneic or in minor histocompatibility antigens-allogeneic mice showed only a weak increase in Db antigens. Such induction of H-2 expression appears to be mediated by the host's immune system, since (1) cells obtained from tumors grown in allogeneic BALB/c nude mice expressed much lower levels of H-2 antigens than those from tumors grown in normal BALB/c mice, and (2) it was possible to induce H-2 expression by growing B16 cells in syngeneic C57Bl/6 mice previously allostimulated with unrelated BALB/c tumor. In vitro treatment with immune interferon restored the expression of both Kb and Db antigens. We hypothesize that H-2 reexpression on B16 cells grown in allogeneic hosts could take place via the nonspecific components of the immune response, such as immune interferon.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939971

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  3 in total

1.  Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.

Authors:  Christopher A Klebanoff; Zhiya Yu; Leroy N Hwang; Douglas C Palmer; Luca Gattinoni; Nicholas P Restifo
Journal:  Blood       Date:  2009-06-26       Impact factor: 22.113

2.  Interferon-mediated enhancement of metastasis. Are MHC antigens involved?

Authors:  P L Lollini; C De Giovanni; B Del Re; G Nicoletti; G Prodi; P Nanni
Journal:  Clin Exp Metastasis       Date:  1987 Oct-Dec       Impact factor: 5.150

3.  Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.

Authors:  P Nanni; L Landuzzi; G Nicoletti; C De Giovanni; M Giovarelli; E Lalli; A Facchini; P L Lollini
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.